Brief: Adaptive Biotechnologies Q3 EPS USD -0.22
07/11/2024 21:05
Nov 07 (Reuters) - Adaptive Biotechnologies Q3 revenue USD 46.435 million vs. IBES estimate USD 40.2 million. * Q3 operating income USD -32.632 million vs. IBES estimate USD -43.2 million * Q3 net income USD -32.097 million vs. IBES estimate USD -43.9 million * Q3 operating expenses USD 79.067 million * Q3 adjusted EBITDA USD -14.3 million vs. IBES estimate USD -23.6 million
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile